SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-003463
Filing Date
2021-11-08
Accepted
2021-11-08 16:10:47
Documents
68
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ziop-20210930.htm   iXBRL 10-Q 2432373
2 EX-4.1 ziop-ex4_1.htm EX-4.1 162233
3 EX-10.1 ziop-ex10_1.htm EX-10.1 801110
4 EX-31.1 ziop-ex31_1.htm EX-31.1 13532
5 EX-31.2 ziop-ex31_2.htm EX-31.2 13700
6 EX-32.1 ziop-ex32_1.htm EX-32.1 10908
  Complete submission text file 0000950170-21-003463.txt   9150902

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ziop-20210930_def.xml EX-101.DEF 317418
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ziop-20210930_cal.xml EX-101.CAL 31464
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ziop-20210930.xsd EX-101.SCH 60605
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ziop-20210930_lab.xml EX-101.LAB 484218
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ziop-20210930_pre.xml EX-101.PRE 402659
12 EXTRACTED XBRL INSTANCE DOCUMENT ziop-20210930_htm.xml XML 1163916
Mailing Address ONE FIRST AVENUE PARRIS BUILDING 34, NAVY YARD PLAZA BOSTON MA 02129
Business Address ONE FIRST AVENUE PARRIS BUILDING 34, NAVY YARD PLAZA BOSTON MA 02129 617-259-1970
ZIOPHARM ONCOLOGY INC (Filer) CIK: 0001107421 (see all company filings)

IRS No.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33038 | Film No.: 211388024
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences